However, in a recent study by Polyzos and colleagues [162], irisin levels were slightly higher in patients with NAFLD and significantly higher in NAFLD patients with portal inflammation, as compared to those without portal inflammation. This evidence concerns the gene FNDC5 and metabolic dysfunction-associated steatotic liver disease.